TY - JOUR AU - Kim, H. PY - 2013 DA - 2013// TI - Alphα -synuclein expression in patients with Parkinson’s disease: a clinician’s perspective JO - Exp Neurobiol VL - 22 UR - https://doi.org/10.5607/en.2013.22.2.77 DO - 10.5607/en.2013.22.2.77 ID - Kim2013 ER - TY - JOUR AU - Mossuto, M. F. PY - 2013 DA - 2013// TI - Disulfide bonding in neurodegenerative misfolding diseases JO - Int J Cell Biol VL - 2013 UR - https://doi.org/10.1155/2013/318319 DO - 10.1155/2013/318319 ID - Mossuto2013 ER - TY - JOUR AU - Mehta, A. K. AU - Rosen, R. F. AU - Childers, W. S. AU - Gehman, J. D. AU - Walker, L. C. AU - Lynn, D. G. PY - 2013 DA - 2013// TI - Context dependence of protein misfolding and structural strains in neurodegenerative diseases JO - Biopolymers VL - 100 UR - https://doi.org/10.1002/bip.22283 DO - 10.1002/bip.22283 ID - Mehta2013 ER - TY - JOUR AU - Kang, J. H. AU - Irwin, D. J. AU - Chen-Plotkin, A. S. AU - Siderowf, A. AU - Caspell, C. AU - Coffey, C. S. PY - 2013 DA - 2013// TI - Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with Parkinson disease JO - JAMA Neurology VL - 70 ID - Kang2013 ER - TY - JOUR AU - Wilkaniec, A. AU - Strosznajder, J. B. AU - Adamczyk, A. PY - 2013 DA - 2013// TI - Toxicity of extracellular secreted alpha synuclein: its role in nitrosative stress and neurodegeneration JO - Neurochem Int VL - 62 UR - https://doi.org/10.1016/j.neuint.2013.02.004 DO - 10.1016/j.neuint.2013.02.004 ID - Wilkaniec2013 ER - TY - JOUR AU - Nagano-Saito, A. AU - Habak, C. AU - Mejia-Constain, B. AU - Degroot, C. AU - Monetta, L. AU - Jubault, T. PY - 2014 DA - 2014// TI - Effect of mild cognitive impairment on the patterns of neural activity in early Parkinson’s disease JO - Neurobiol Aging VL - 35 UR - https://doi.org/10.1016/j.neurobiolaging.2013.06.025 DO - 10.1016/j.neurobiolaging.2013.06.025 ID - Nagano-Saito2014 ER - TY - JOUR AU - Pereira, J. B. AU - Junque, C. AU - Bartres-Faz, D. AU - Ramirez-Ruiz, B. AU - Marti, M. J. AU - Tolosa, E. PY - 2013 DA - 2013// TI - Regional vulnerability of Hippocampal subfields and memory deficits in Parkinson’s disease JO - Hippocampus VL - 23 UR - https://doi.org/10.1002/hipo.22131 DO - 10.1002/hipo.22131 ID - Pereira2013 ER - TY - JOUR AU - Korff, A. AU - Liu, C. AU - Ginghina, C. AU - Shi, M. AU - Zhang, J. PY - 2013 DA - 2013// TI - α-synuclein in cerebrospinal fluid of Alzheimer’s disease and mild cognitive impairment JO - J Alzheimer Dis VL - 36 ID - Korff2013 ER - TY - JOUR AU - Kalia, L. V. AU - Kalia, S. K. AU - McLean, P. J. AU - Lozano, A. M. AU - Lang, A. E. PY - 2013 DA - 2013// TI - Alpha‐synuclein oligomers and clinical implications for Parkinson disease JO - Ann Neurol VL - 73 UR - https://doi.org/10.1002/ana.23746 DO - 10.1002/ana.23746 ID - Kalia2013 ER - TY - JOUR AU - Bartels, T. AU - Choi, J. G. AU - Selkoe, D. J. PY - 2011 DA - 2011// TI - Alpha-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation JO - Nature VL - 477 UR - https://doi.org/10.1038/nature10324 DO - 10.1038/nature10324 ID - Bartels2011 ER - TY - JOUR AU - Bonini, N. M. AU - Giasson, B. I. PY - 2005 DA - 2005// TI - Snaring the function of α-synuclein JO - Cell VL - 123 UR - https://doi.org/10.1016/j.cell.2005.10.017 DO - 10.1016/j.cell.2005.10.017 ID - Bonini2005 ER - TY - JOUR AU - Abeliovich, A. AU - Schmitz, Y. AU - Fariñas, I. AU - Choi-Lundberg, D. AU - Ho, W. H. AU - Castillo, P. E. PY - 2000 DA - 2000// TI - Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system JO - Neuron VL - 25 UR - https://doi.org/10.1016/S0896-6273(00)80886-7 DO - 10.1016/S0896-6273(00)80886-7 ID - Abeliovich2000 ER - TY - JOUR AU - Manning-Bog, A. B. AU - McCormack, A. L. AU - Purisai, M. G. AU - Bolin, L. M. AU - Monte, D. A. PY - 2003 DA - 2003// TI - α-synuclein overexpression protects against paraquat-induced neurodegeneration JO - J Neurosci VL - 23 ID - Manning-Bog2003 ER - TY - JOUR AU - Darios, F. AU - Ruipérez, V. AU - López, I. AU - Villanueva, J. AU - Gutierrez, L. M. AU - Davletov, B. PY - 2010 DA - 2010// TI - Alpha‐Synuclein sequesters arachidonic acid to modulate SNARE‐mediated exocytosis JO - EMBO Rep VL - 11 UR - https://doi.org/10.1038/embor.2010.66 DO - 10.1038/embor.2010.66 ID - Darios2010 ER - TY - JOUR AU - Kokhan, V. S. AU - Afanasyeva, M. A. AU - Van’kin, G. I. PY - 2012 DA - 2012// TI - α-synuclein knockout mice have cognitive impairments JO - BehavBrain Res VL - 231 ID - Kokhan2012 ER - TY - JOUR AU - Chen, P. E. AU - Specht, C. G. AU - Morris, R. AU - Schoepfer, R. PY - 2002 DA - 2002// TI - Spatial learning is unimpaired in mice containing a deletion of the alphα -synuclein locus JO - Eur J Neurosci VL - 16 UR - https://doi.org/10.1046/j.1460-9568.2002.02062.x DO - 10.1046/j.1460-9568.2002.02062.x ID - Chen2002 ER - TY - JOUR AU - Ullman, O. 1. AU - Fisher, C. K. AU - Stultz, C. M. PY - 2011 DA - 2011// TI - Explaining the structural plasticity of α-synuclein JO - J Am Chem Soc VL - 133 UR - https://doi.org/10.1021/ja208657z DO - 10.1021/ja208657z ID - Ullman2011 ER - TY - JOUR AU - Illes-Toth, E. AU - Dalton, C. F. AU - Smith, D. P. PY - 2013 DA - 2013// TI - Binding of dopamine to alphα -synuclein is mediated by specific conformational states JO - J Am Soc Mass Spectrom VL - 24 UR - https://doi.org/10.1007/s13361-013-0676-z DO - 10.1007/s13361-013-0676-z ID - Illes-Toth2013 ER - TY - JOUR AU - Colloby, S. J. AU - McParland, S. AU - O’Brien, J. T. AU - Attems, J. PY - 2012 DA - 2012// TI - Neuropathological correlates of dopaminergic imaging in Alzheimer’s disease and Lewy body dementias JO - Brain: AJournal of Neurology VL - 135 UR - https://doi.org/10.1093/brain/aws211 DO - 10.1093/brain/aws211 ID - Colloby2012 ER - TY - JOUR AU - Fantini, J. AU - Yahi, N. PY - 2013 DA - 2013// TI - The driving force of alphα -synuclein insertion and amyloid channel formation in the plasma membrane of neural cells: Key role of ganglioside-and cholesterol-binding domains JO - Adv Exp Med Biol VL - 991 UR - https://doi.org/10.1007/978-94-007-6331-9_2 DO - 10.1007/978-94-007-6331-9_2 ID - Fantini2013 ER - TY - JOUR AU - Diogenes, M. J. AU - Dias, R. B. AU - Rombo, D. M. AU - Vicente Miranda, H. AU - Maiolino, F. AU - Guerreiro, P. PY - 2012 DA - 2012// TI - Extracellular alphα -synuclein oligomers modulate synaptic transmittion and impair LTP via NMDA-receptor activation JO - J Neurosci VL - 32 UR - https://doi.org/10.1523/JNEUROSCI.0234-12.2012 DO - 10.1523/JNEUROSCI.0234-12.2012 ID - Diogenes2012 ER - TY - JOUR AU - Resende, R. AU - Marques, S. C. AU - Ferreiro, E. AU - Simoes, I. AU - Oliveira, C. R. AU - Pereira, C. M. PY - 2013 DA - 2013// TI - Effect of α-synuclein on amyloid β-induced toxicity: relevance to Lewy body variant of Alzheimer disease JO - Neurochem Res VL - 38 UR - https://doi.org/10.1007/s11064-013-0982-7 DO - 10.1007/s11064-013-0982-7 ID - Resende2013 ER - TY - JOUR AU - Stefanis, L. PY - 2012 DA - 2012// TI - α-synuclein in Parkinson’s disease JO - Cold Spring Harbor Perspectives in Medicine VL - 2 UR - https://doi.org/10.1101/cshperspect.a009399 DO - 10.1101/cshperspect.a009399 ID - Stefanis2012 ER - TY - JOUR AU - Tateno, F. AU - Sakakibara, R. AU - Kawai, T. AU - Kishi, M. AU - Murano, T. PY - 2012 DA - 2012// TI - Alpha-synuclein in the cerebrospinal fluid differentiates synucleinopathies (Parkinson Disease, dementia with Lewy bodies, multiple system atrophy) from Alzheimer disease JO - Alzheimer Dis Assoc Disord VL - 26 UR - https://doi.org/10.1097/WAD.0b013e31823899cc DO - 10.1097/WAD.0b013e31823899cc ID - Tateno2012 ER - TY - JOUR AU - Vasudevaraju, P. AU - Guerrero, E. AU - Hegde, M. L. AU - Collen, T. B. AU - Britton, G. B. AU - Rao, K. S. PY - 2012 DA - 2012// TI - New evidence on alpha-synuclein and Tau binding to conformation and sequence specific GC* rich DNA: Relevance to neurological disorders JO - J Pharm Bioallied Sci VL - 4 UR - https://doi.org/10.4103/0975-7406.94811 DO - 10.4103/0975-7406.94811 ID - Vasudevaraju2012 ER - TY - JOUR AU - Marques, O. AU - Outeiro, T. F. PY - 2012 DA - 2012// TI - Alphα -synuclein:from secretion to dysfunction and death JO - Cell Death and Disease VL - 3 UR - https://doi.org/10.1038/cddis.2012.94 DO - 10.1038/cddis.2012.94 ID - Marques2012 ER - TY - JOUR AU - Guo, J. L. AU - Covell, D. J. AU - Daniels, J. P. AU - Iba, M. AU - Stieber, A. AU - Zhang, B. PY - 2013 DA - 2013// TI - Distinct alpha-synuclein strains differentially promote tau inclusions in neurons JO - Cell VL - 154 UR - https://doi.org/10.1016/j.cell.2013.05.057 DO - 10.1016/j.cell.2013.05.057 ID - Guo2013 ER - TY - JOUR AU - Wang, D. S. AU - Bennett, D. A. AU - Mufson, E. AU - Cochran, E. AU - Dickson, D. W. PY - 2004 DA - 2004// TI - Decreases in soluble alpha-synuclein in frontal cortex correlate with cognitive decline in the elderly JO - Neurosci Lett VL - 359 ID - Wang2004 ER - TY - JOUR AU - Rao, A. V. AU - Balachandran, B. PY - 2002 DA - 2002// TI - Role of oxidative stress and antioxidants in neurodegenerative diseases JO - Nutr Neurosci VL - 5 UR - https://doi.org/10.1080/1028415021000033767 DO - 10.1080/1028415021000033767 ID - Rao2002 ER - TY - JOUR AU - Martin, Z. S. AU - Neugebauer, V. AU - Dineley, K. T. AU - Kayed, R. AU - Zhang, W. AU - Reese, L. C. PY - 2012 DA - 2012// TI - alpha-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases JO - J Neurochem VL - 120 UR - https://doi.org/10.1111/j.1471-4159.2011.07576.x DO - 10.1111/j.1471-4159.2011.07576.x ID - Martin2012 ER - TY - JOUR AU - Grathwohl, S. A. AU - Steiner, J. A. AU - Britschgi, M. AU - Brundin, P. PY - 2013 DA - 2013// TI - Mind the gut: secretion of alpha-synuclein by enteric neurons JO - J Neurochem VL - 125 UR - https://doi.org/10.1111/jnc.12191 DO - 10.1111/jnc.12191 ID - Grathwohl2013 ER - TY - JOUR AU - Chai, Y. J. AU - Kim, D. AU - Park, J. AU - Zhao, H. AU - Lee, S. J. AU - Chang, S. PY - 2013 DA - 2013// TI - The secreted oligomeric form of alpha-synuclein affects multiple steps of membrane trafficking JO - FEBS Lett VL - 587 UR - https://doi.org/10.1016/j.febslet.2013.01.008 DO - 10.1016/j.febslet.2013.01.008 ID - Chai2013 ER - TY - JOUR AU - Larson, M. E. AU - Sherman, M. A. AU - Greimel, S. AU - Kuskowski, M. AU - Schneider, J. A. AU - Bennett, D. A. PY - 2012 DA - 2012// TI - Soluble alpha-synuclein is a novel modulator of Alzheimer’s disease pathophysiology JO - J Neurosci VL - 32 UR - https://doi.org/10.1523/JNEUROSCI.0581-12.2012 DO - 10.1523/JNEUROSCI.0581-12.2012 ID - Larson2012 ER - TY - JOUR AU - Xu, G. AU - Stevens, S. M. AU - Moore, B. D. AU - McClung, S. AU - Borchelt, D. R. PY - 2013 DA - 2013// TI - Cytosolic proteins lose solubility as amyloid deposits in a transgenic mouse model of Alzheimer-type amyloidosis JO - Hum Mol Genet VL - 22 UR - https://doi.org/10.1093/hmg/ddt121 DO - 10.1093/hmg/ddt121 ID - Xu2013 ER - TY - JOUR AU - Hamilton, R. L. PY - 2000 DA - 2000// TI - Lewy bodies in Alzheimer’s disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry JO - Brain Pathol VL - 10 UR - https://doi.org/10.1111/j.1750-3639.2000.tb00269.x DO - 10.1111/j.1750-3639.2000.tb00269.x ID - Hamilton2000 ER - TY - JOUR AU - Jellinger, K. A. AU - Attems, J. PY - 2008 DA - 2008// TI - Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease JO - Acta Neuropathol VL - 115 UR - https://doi.org/10.1007/s00401-008-0347-5 DO - 10.1007/s00401-008-0347-5 ID - Jellinger2008 ER - TY - JOUR AU - Postuma, R. B. PY - 2013 DA - 2013// TI - Comment: epidemiology of dementia with Lewy bodies–the Alzheimer-Parkinson overlap JO - Neurology VL - 81 UR - https://doi.org/10.1212/WNL.0b013e3182a2cc8e DO - 10.1212/WNL.0b013e3182a2cc8e ID - Postuma2013 ER - TY - JOUR AU - Li, J. AU - Liu, D. AU - Sun, L. AU - Lu, Y. AU - Zhang, Z. PY - 2012 DA - 2012// TI - Advanced glycation end products and neurodegenerative diseases: mechanisms and perspective JO - J Neurol Sci VL - 317 UR - https://doi.org/10.1016/j.jns.2012.02.018 DO - 10.1016/j.jns.2012.02.018 ID - Li2012 ER - TY - JOUR AU - Gold, A. AU - Turkalp, Z. T. AU - Munoz, D. G. PY - 2013 DA - 2013// TI - Enteric alpha-synuclein expression is increased in Parkinson’s disease but not Alzheimer’s disease JO - Mov Disord VL - 28 UR - https://doi.org/10.1002/mds.25298 DO - 10.1002/mds.25298 ID - Gold2013 ER - TY - JOUR AU - Irwin, D. J. AU - Abrams, J. Y. AU - Schonberger, L. B. AU - Leschek, E. W. AU - Mills, J. L. AU - Lee, V. M. PY - 2013 DA - 2013// TI - Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone JO - JAMA Neurol VL - 70 UR - https://doi.org/10.1001/jamaneurol.2013.1933 DO - 10.1001/jamaneurol.2013.1933 ID - Irwin2013 ER - TY - JOUR AU - Hashimoto, M. AU - Rockenstein, E. AU - Mante, M. AU - Crews, L. AU - Bar-On, P. AU - Gage, F. H. PY - 2004 DA - 2004// TI - An antiaggregation gene therapy strategy for Lewy body disease utilizing beta-synuclein lentivirus in a transgenic model JO - Gene Ther VL - 11 UR - https://doi.org/10.1038/sj.gt.3302349 DO - 10.1038/sj.gt.3302349 ID - Hashimoto2004 ER - TY - BOOK AU - Ghanbari, H. A. AU - Potomac, M. D. AU - Ghanbari, K. PY - 2012 DA - 2012// TI - Compositions and methods for preventing protein aggregation in neurodegenerative diseases PB - United States Patient Application Publication CY - United States ID - Ghanbari2012 ER - TY - JOUR AU - Weinreb, O. PY - 2004 DA - 2004// TI - Neurological mechanisms of polyphenols in Alzheimer’s and Parkinson’s diseases JO - J Nutr Biochem VL - 15 UR - https://doi.org/10.1016/j.jnutbio.2004.05.002 DO - 10.1016/j.jnutbio.2004.05.002 ID - Weinreb2004 ER -